A study from The University of Texas MD Anderson Cancer Center recommends using intensity-modulated radiotherapy over 3D-conformal radiotherapy for locally advanced non-small cell lung cancer due to fewer side effects and similar survival outcomes.
Researchers at Moffitt Cancer Center in Tampa, Fla., are modeling how interactions between cancer cells and immune cells, along with their subsequent responses to radiation, impact a tumor.
The CyberKnife System’s motion synchronization technology uses AI to adapt radiation delivery in real-time to patient and/or tumor movement throughout the course of treatment.
Sunnyvale, Calif.-based Accuray Incorporated has signed a multisystem, multihospital agreement with Mercy health system for the acquisition of Accuray Radixact and CyberKnife M6 systems, building on a 13-year relationship designed to expand access to advanced, lifesaving technology for more cancer patients.
Read More
Cancer patients in the Washington, D.C. metropolitan region have access to proton radiation therapy, now available at the MedStar Georgetown University Hospital Proton Therapy Center.
Read More